药明康德: 无锡药明康德新药开发股份有限公司银行间债券市场非金融企业债务融资工具信息披露管理制度(2025年修订)
Zheng Quan Zhi Xing·2025-09-02 10:25

Core Points - The document outlines the information disclosure management system for Wuxi WuXi AppTec Co., Ltd. regarding the issuance of non-financial corporate debt financing instruments in the interbank bond market, aiming to standardize disclosure practices and protect investor rights [1][2][3] Group 1: General Principles - The system is established to regulate the information disclosure behavior of the company in the interbank bond market, ensuring compliance with relevant laws and regulations [1][2] - The term "debt financing instruments" refers to securities issued in the interbank bond market that promise repayment of principal and interest within a specified period [1][2] Group 2: Disclosure Obligations - The company must disclose information that may significantly impact its debt repayment ability or investor rights during the issuance and throughout the life of the debt financing instruments [2][5] - Information must be disclosed in a timely and fair manner, ensuring that all disclosures are truthful, accurate, and complete, without any misleading statements or omissions [2][3] Group 3: Disclosure Content and Standards - The issuance documents must include the company's audited financial reports for the last three years and the most recent accounting statements [4][6] - The company is required to disclose the results of the issuance, including the actual issuance scale, term, and price, no later than the first trading day of the debt financing instruments [4][5] Group 4: Ongoing Disclosure Requirements - During the life of the debt financing instruments, the company must disclose annual reports within four months after the end of each fiscal year, semi-annual reports within two months after the end of the first half of the fiscal year, and quarterly financial statements within one month after the end of each quarter [5][6] - Significant events that may affect the company's debt repayment ability or investor rights must be disclosed promptly, including changes in company name, major operational changes, and changes in key personnel [6][7] Group 5: Management of Disclosure Affairs - The Chief Financial Officer is designated as the person responsible for managing the information disclosure affairs related to debt financing instruments [12][13] - The finance department is responsible for the management of information disclosure related to debt financing instruments [12][13] Group 6: Confidentiality and Internal Control - The company must implement measures to protect insider information and ensure that no unauthorized individuals can access or disclose such information [17][18] - Internal audits must be conducted to ensure the accuracy and confidentiality of financial information before disclosure [18][19]